ImmuPharma plc (LON:IMM – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1.70 ($0.02) and traded as high as GBX 2.20 ($0.03). ImmuPharma shares last traded at GBX 2.04 ($0.03), with a volume of 685,961 shares changing hands.
ImmuPharma Price Performance
The stock has a market cap of £8.37 million, a price-to-earnings ratio of -203.50 and a beta of 1.32. The company’s fifty day moving average price is GBX 1.88 and its 200-day moving average price is GBX 1.70.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Articles
- Five stocks we like better than ImmuPharma
- Dividend Payout Ratio Calculator
- AMD is Down 35%. Now is the Time to Buy the Dip
- How to Calculate Inflation Rate
- Amazon Stands Tall: New Highs Are in Sight
- What is the NASDAQ Stock Exchange?
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
